SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: BigKahuna, BooDog, TOB, sox040713, Astavakra, TheHound
Search This Board:
Last Post: 10/1/2016 4:16:17 AM - Followers: 705 - Board type: Free - Posts Today: 2

Cellceutix Corporation (CTIX)
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
About Cellceutix: 

Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Cellceutix is now preparing its FDA application for a Phase 2 ovarian cancer study. In the laboratory, Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is in a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of Oral Mucositis in patients with head and neck cancer. Brilacidin-OM, a defensin mimetic compound, has shown in an animal model to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol completed a Phase 2 trial. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria (Superbugs). Brilacidin is also being evaluated in a Phase 2 Proof-of-Concept trial as a novel treatment for Ulcerative Proctitis. Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available on the Cellceutix web site at www.cellceutix.com. 

Management:  http://cellceutix.com/team/

Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

 

Upcoming Milestones:
 


Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings (CIK:0001355250):  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:

EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275

 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CTIX News: Current Report Filing (8-k) 09/15/2016 08:01:38 AM
CTIX News: Current Report Filing (8-k) 09/13/2016 08:01:27 AM
CTIX News: Annual Report (10-k) 09/13/2016 06:04:52 AM
CTIX News: Insider Financial Publishes New Research On Three Promising Biotechs 07/16/2016 08:00:00 AM
CTIX News: Securities Registration: Employee Benefit Plan (s-8) 07/15/2016 04:52:11 PM
PostSubject
#159155  Sticky Note Chart showing 2016 Milestones KarinCA 09/13/16 02:49:10 PM
#158037  Sticky Note 9-1-16 New Cellceutix Report Out. Worth a read imo. TheHound 09/01/16 08:36:02 AM
#156616  Sticky Note Interview With New Cellceutix President Dr A Bertolino BigKahuna 08/11/16 11:49:13 PM
#156603  Sticky Note CTIX Interviews, Potential Catalysts and Past Milestones sox040713 08/11/16 06:13:05 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#160620   If it's a limit order it doesn't matter. BigKahuna 10/01/16 04:16:17 AM
#160619   If you sell, you might need to sell TheBunny 10/01/16 01:17:47 AM
#160618   Info has to be both: 1) Material and 2) ericseb2003 09/30/16 09:24:05 PM
#160617   the information in reference to my initial response TheHound 09/30/16 08:56:56 PM
#160616   You can always sell on Monday. EasyRider 09/30/16 08:48:03 PM
#160615   Info has to be both: 1) Material and 2) ericseb2003 09/30/16 08:44:01 PM
#160614   just for shits and giggles, and for the TheHound 09/30/16 07:47:25 PM
#160613   Lip to sip. Ha! Never heard scottsmith 09/30/16 07:37:55 PM
#160612   Did management guarantee success? If yes, please provide sox040713 09/30/16 07:19:50 PM
#160611   Please do, this asylum/board is being run by eventhelosers 09/30/16 07:16:24 PM
#160610   I assume you're kidding. If not, I'll respond. loanranger 09/30/16 07:04:12 PM
#160609   FINRA short sales of CTIX AlanC 09/30/16 06:22:32 PM
#160608   Cellceutix's Prurisol georgejjl 09/30/16 06:01:13 PM
#160607   The lack of a partnership ails me!! I casher 09/30/16 05:44:00 PM
#160606   Hope whatever ails you gets resolved in your favor! BIzzy 09/30/16 05:36:38 PM
#160605   4th quarter of calendar year starts tomorrow. DaubersUP 09/30/16 05:34:17 PM
#160604   Don't get too excited, it was me. I casher 09/30/16 05:30:13 PM
#160603   Interesting. Here I thought it was illegal when TheHound 09/30/16 04:50:20 PM
#160602   "There is a seller showing his hand, it's loanranger 09/30/16 04:41:42 PM
#160601   Not so! loanranger 09/30/16 04:35:24 PM
#160600   As they there is a big gap between Amatuer17 09/30/16 04:10:00 PM
#160598   One drug is a lock and another can't scottsmith 09/30/16 03:44:23 PM
#160597   I hope so SS but I have my doubts tombrady12nh 09/30/16 03:22:32 PM
#160596   We are the smart money. scottsmith 09/30/16 03:20:01 PM
#160595   Big Kahuna Isn't there a report out soon? Echo20 Echo20 09/30/16 03:12:42 PM
#160594   In the long run you will be either luxe 09/30/16 03:07:29 PM
#160593   Did you read my post? There is a luxe 09/30/16 03:04:40 PM
#160591   38k shares and you think there is selling? BigKahuna 09/30/16 02:59:48 PM
#160590   It won't matter in the long run. KarinCA 09/30/16 02:54:02 PM
#160589   80% of the total volume today 29,700 shares luxe 09/30/16 02:49:56 PM
#160588   Fungal microbiota dysbiosis in IBD. georgejjl 09/30/16 02:28:11 PM
#160587   An immunological link between Candida albicans colonization and georgejjl 09/30/16 02:23:52 PM
#160586   31k vollie-hate to tell y'all BP eyes aren't tombrady12nh 09/30/16 02:14:04 PM
#160585   ool ool I do I do!!! runninggirl2016 09/30/16 01:54:42 PM
#160584   Does anyone know of a company developing a georgejjl 09/30/16 01:45:13 PM
#160583   There must be 2 more as well! AlanC 09/30/16 12:45:18 PM
#160582   Haha SS tombrady12nh 09/30/16 12:40:28 PM
#160581   or SIDEWAYS. TheHound 09/30/16 12:04:20 PM
#160580   or DOWN. loanranger 09/30/16 11:30:22 AM
#160579   Me, you, and george have a 100 percent scottsmith 09/30/16 10:28:51 AM
#160577   Ha ha sorry forgot I was in the UK... Steinvid 09/30/16 10:07:42 AM
#160575   Premarket...?? Steinvid 09/30/16 09:51:26 AM
#160574   I'm predicting HUGE NEWS in November or December tombrady12nh 09/30/16 09:42:07 AM
#160571   lmao. good call. TheHound 09/30/16 09:25:15 AM
#160570   Insiders are prohibited by the SEC from trading georgejjl 09/30/16 09:24:21 AM
#160569   From the SEC (US Securities and Exchange Commission) georgejjl 09/30/16 09:13:53 AM
#160567   Snayeman: By definition news is previously unknown information. georgejjl 09/30/16 09:05:08 AM
#160565   George, with all due respect I don't think snayeman 09/30/16 08:44:37 AM
#160564   I was proven correct yet again. We did georgejjl 09/30/16 08:39:38 AM
#160561   That's great George. Are we getting HUGE NEWS TOMORROW!!?? frrol 09/30/16 08:22:19 AM
PostSubject